Enlaza Therapeutics is a biotechnology research company.
Enlaza Therapeutics has raised $15.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.
Enlaza Therapeutics's investors include Lightspeed Venture Partners, Samsara BioCapital, Frazier Life Sciences, Regeneron, J.P. Morgan Asset Management.
Enlaza Therapeutics is headquartered in La Jolla, United States.
Enlaza Therapeutics is a biotechnology research company.
Enlaza Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Enlaza Therapeutics — Funding & Investors." VCBacked, September 10, 2025, https://www.vcbacked.co/company/enlaza-therapeutics. Accessed July 19, 2026.
VCBacked. (2025). Enlaza Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/enlaza-therapeutics
{{cite web |title=Enlaza Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/enlaza-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated